EU generic drugmakers flag risks to production due to rising costs

Sep. 27, 2022 1:16 PM ETViatris Inc. (VTRS)NVS, TEVA, NVSEF, AMPHBy: Dulan Lokuwithana, SA News Editor1 Comment

Close Up of Various Pills and Capsules

solarseven/iStock via Getty Images

A lobby group representing the generic drugmakers in Europe has pointed out that the cost inflation, rising energy costs, and price control policies have made manufacturing in the region unsustainable.

In an open letter on

Recommended For You

Comments (1)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.